LoginSignup
OGN

Organon

Stock
Stock
ISIN: US68622V1061
Ticker: OGN
US68622V1061
OGN

Price

Price

Historical dividends and forecast

All dividend data

Organon has so far distributed $0.84 in 2024. The next dividend will be paid on 12.12.2024

$1.008

CHART BY

Frequently asked questions

What is Organon's market capitalization?

The market capitalization of Organon is $3.94B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Organon's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Organon is 3.03. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Organon?

Organon's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.042. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Organon's stock?

Currently, 9 analysts cover Organon's stock, with a consensus target price of $22.38. Analyst ratings provide insights into the stock's expected performance.

What is Organon's revenue over the trailing twelve months?

Over the trailing twelve months, Organon reported a revenue of $6.41B.

Is Organon paying dividends?

Yes, Organon is paying dividends. The next payment is scheduled for 12.12.2024, with an expected amount of .

What is the EBITDA for Organon?

Organon's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.75B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Organon?

Organon has a free cash flow of $350.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Organon's stock?

The 5-year beta for Organon is 0.72. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Organon have, and what sector and industry does it belong to?

Organon employs approximately 10,000 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Organon's shares?

The free float of Organon is 257.08M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $3.94B

5Y beta

 0.72

EPS (TTM)

 $5.042

Free Float

 257.08M

P/E ratio (TTM)

 3.03

Revenue (TTM)

 $6.41B

EBITDA (TTM)

 $1.75B

Free Cashflow (TTM)

 $350.00M

Pricing

1D span
$14.58$15.47
52W span
$10.84$23.10

Analyst Ratings

The price target is $22.38 and the stock is covered by 9 analysts.

Buy

4

Hold

4

Sell

1

Information

Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions. Its portfolio also includes VTAMA (tapinarof) cream, 1%, a nonbiologic, non-steroidal topical therapy, for treatment of mild, moderate, and severe plaque psoriasis in adults.

10,000

Biotechnology & Drugs

Health Care

Identifier

ISIN

US68622V1061

Primary Ticker

OGN

Knockouts

Join the conversation
Sign upLogin